Events

Innovation Fund National Infoday 2025
FEB
Tue
11
09:00 - 16:00

This was 5 months ago

Location

Brussels

Belpaire-building, Simon Bolivarlaan 17, 1000 Brussel
Programmes
Digital, Industry & Space Climate, Energy, Mobility EIC Digital Europe

This event will bring together key stakeholders from industry, research, and public authorities to discuss opportunities under the Innovation Fund, one of Europe’s most ambitious programs for supporting innovation in clean technologies.

There will be representatives from DG CLIMATE ACTION of the European Commission and CINEA (European Climate, Infrastructure and Environment Executive Agency), who will provide valuable insights into the fund’s objectives, application process, and upcoming calls for proposals.

Participation is free, but places are limited.

Information on the full agenda and registration can be found here .

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.